IMXI Clinical Immix Biopharma Announces Other Serious Diseases Strategy Published August 06, 2025 at 04:30 PM – Dosing ongoing and planned in a handful of Other Serious Diseases (OSD) – Find similar articles on Candlesense globenewswire